Skip to Content

Press Releases

Dr. Bucshon Supports FDA’s Emergency Use Authorization for First at Home COVID-19 Test

(Washington, D.C.) – Congressman Larry Bucshon, M.D. (IN-08) released the following statement after an announcement that the first COVID-19 diagnostic test for self-testing at home, which provides rapid results, has been issued an Emergency Use Authorization (EUA) by the FDA:

This announcement is a tremendous moment in the fight against COVID-19. Since the beginning of this health care crisis, I have been advocating for increased accessed to testing for all Americans. In order to mitigate risk and continue safely reopening our economy, testing must remain a top priority. Now, instead of waiting in long lines and exposing health care workers, Americans can stay at home and test themselves with this FDA authorized at-home, rapid test that provides results in 30 minutes or less. I am greatly encouraged by the great work our scientists are doing in the fight against COVID-19.”


Larry Bucshon, M.D. introduced two pieces of bipartisan legislation back in May to increase diagnostic testing capabilities at public health laboratories and expand testing access to hospitals, physicians and other health service providers that were included in H.R. 14:

·       Diagnostic Testing for Public Health Labs Act

·       Rapid Testing for Communities Act